Qiyang Cheng
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 20, 2023
Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis.
Journal: World journal of surgical oncology
Published: December 30, 2020
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Journal: Cancer letters
Published: July 30, 2020
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.
Journal: Molecular cancer
Published: February 10, 2020
LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.
Journal: American journal of cancer research
Published: September 10, 2019
NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Journal: International journal of biological sciences
Published: August 23, 2019
Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma.
Journal: American journal of cancer research
Published: April 10, 2018
Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma: Case report.
Journal: Medicine
Published: February 03, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026